Risk factors for treatment failure in scabies: a cohort study

被引:32
|
作者
Aussy, A. [1 ,2 ]
Houivet, E. [3 ,4 ]
Hebert, V. [1 ,2 ]
Colas-Cailleux, H. [1 ,2 ]
Laaengh, N. [1 ,2 ]
Richard, C. [1 ,2 ]
Ouvry, M. [1 ,2 ]
Boulard, C. [1 ,2 ]
Leger, S. [1 ,2 ]
Litrowski, N. [1 ,2 ]
Benichou, J. [3 ,4 ]
Joly, P. [1 ,2 ]
Bechu, S.
Mion-Mouton, N.
Lafaurie, O.
Barrel, A.
Pulluard, M.
Hamel, V.
Dore, M. X.
Duflo, E.
Lardans-Cassius, S.
Rzeznik, J. C.
Baricault, S.
机构
[1] Rouen Univ Hosp, Dept Dermatol, Rouen, France
[2] Univ Rouen Normandie, INSERM, U1234, Rouen, France
[3] Rouen Univ Hosp, Dept Biostat, Rouen, France
[4] Univ Rouen Normandie, INSERM, U1219, Rouen, France
关键词
ORAL IVERMECTIN; PREVALENCE; EPIDEMIOLOGY; CREAM;
D O I
10.1111/bjd.17348
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Treatment failure, which occurs in about one-third of cases, is considered as a major factor in the increasing incidence of scabies in developed countries. Objectives To identify predictors of treatment failure of scabies in ambulatory populations. Methods This multicentre study compared the clinical characteristics and treatment modalities between a group of patients with scabies treated successfully and another group who were not cured 3 months after antiscabies treatment. Results In total 210 patients with a diagnosis of scabies were included, comprising 98 patients in the treatment success group and 112 in the treatment failure group. The main risk factors for treatment failure were (i) the use of only one type of treatment, topical benzyl benzoate (BB) or oral ivermectin, vs. the combination of both treatments [odds ratio (OR) 2 center dot 15, 95% confidence interval (CI) 1 center dot 22-3 center dot 77]; (ii) the use of a single intake (vs. two) of oral ivermectin (OR 10 center dot 2. 95% CI 4 center dot 49-23 center dot 2); (iii) intake of ivermectin during a meal vs. on an empty stomach (OR 4 center dot 31, 95% CI 1 center dot 89-9 center dot 84); (iv) absence of decontamination of furnishings (OR 8 center dot 72, 95% CI 3 center dot 50-21 center dot 8), in particular sofa and cushions (OR 5 center dot 90, 95% CI 2 center dot 34-14 center dot 9), mattresses (OR 4 center dot 16, 95% CI 1 center dot 35-12 center dot 8) or car seats (OR 6 center dot 57, 95% CI 3 center dot 27-13 center dot 2) and (v) absence of written documents explaining treatment modalities (OR 5 center dot 18, 95% CI 2 center dot 57-10 center dot 4). In multivariate analysis, treatment failure was mainly associated with (i) use of a single intake (vs. two) of ivermectin (OR 6 center dot 62, 95% CI 2 center dot 71-16 center dot 2); (ii) use of BB alone vs. two intakes of ivermectin (OR 3 center dot 51, 95% CI 1 center dot 55-7 center dot 95) and (iii) absence of decontamination of furniture with acaricides (OR 5 center dot 81, 95% CI 1 center dot 96-16 center dot 7). Conclusions Use of topical BB alone and a single intake (vs. two) of ivermectin are predictors of treatment failure.
引用
收藏
页码:888 / 893
页数:6
相关论文
共 50 条
  • [41] Factors associated with syphilis treatment failure and reinfection: a longitudinal cohort study in Shenzhen, China
    Luo, Zhenzhou
    Zhu, Lin
    Ding, Yi
    Yuan, Jun
    Li, Wu
    Wu, Qiuhong
    Tian, Lishan
    Zhang, Li
    Zhou, Guomao
    Zhang, Tao
    Ma, Jianping
    Chen, Zhongwei
    Yang, Tubao
    Feng, Tiejian
    Zhang, Min
    BMC INFECTIOUS DISEASES, 2017, 17
  • [42] A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis
    Bosch-Nicolau, Pau
    Falco, Vicenc
    Vinado, Belen
    Andreu, Antonia
    Len, Oscar
    Almirante, Benito
    Pigrau, Carles
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [43] Risk factors for pneumothorax after treatment with endobronchial valves; a retrospective cohort study
    Jorgensen, Kirstine Hermann
    Christensen, Thomas Decker
    Titlestad, Ingrid Louise
    Davidsen, Jesper Romhild
    Bock, Kathrine
    Jensen, Kristine
    Perch, Michael
    Bendixen, Morten
    Jorgensen, Ole Dan
    Bendstrup, Elisabeth
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [44] Risk factors for treatment failure of anisometropic amblyopia
    Hussein, MAW
    Coats, DK
    Muthialu, A
    Cohen, E
    Paysse, EA
    JOURNAL OF AAPOS, 2004, 8 (05): : 429 - 434
  • [45] Surgical treatment of obesity and excess risk of developing heart failure in a controlled cohort study
    Lundberg, Christina E.
    Jamaly, Shabbar
    Adiels, Martin
    Lagergren, Jesper
    Svensson, Carl Johan
    Bjoerck, Lena
    Rosengren, Annika
    ESC HEART FAILURE, 2022, 9 (03): : 1844 - 1852
  • [46] Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study
    de Fendi, Ligia Issa
    de Oliveira, Tiago Cena
    Pereira, Carolina Bigheti
    Bigheti, Carina Pereira
    Viani, Gustavo A.
    JOURNAL OF GLAUCOMA, 2016, 25 (10) : E879 - E883
  • [47] CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF ADULT PATIENTS WITH SCABIES INFECTION: A RETROSPECTIVE COHORT STUDY
    Fungtrakoon, Sasit
    Leeyaphan, Charussri
    Arunkajohnsak, Sittiroj
    Kanchanapenkul, Dollaporn
    Matthapan, Lalita
    Lertrujiwanit, Kamonpan
    Prasong, Waranyoo
    Bunyaratavej, Sumanas
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2019, 50 (01) : 162 - 169
  • [48] Exploring risk factors of short-term readmission in heart failure patients: A cohort study
    Niu, Xiao Na
    Wen, He
    Sun, Nan
    Zhao, Ran
    Wang, Ting
    Li, Yan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [49] Risk factors and outcomes for acute respiratory failure in coronavirus disease 2019: An observational cohort study
    Piwowarczyk, Pawel
    Szczukocka, Marta
    Kutnik, Pawel
    Borys, Michal
    Miklaszewska, Anna
    Kiciak, Slawomir
    Czuczwar, Miroslaw
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 30 (02): : 165 - 171
  • [50] Age dependent associations of risk factors with heart failure: pooled population based cohort study
    Tromp, Jasper
    Paniagua, Samantha M. A.
    Lau, Emily S.
    Allen, Norrina B.
    Blaha, Michael J.
    Gansevoort, Ron T.
    Hillege, Hans L.
    Lee, Douglas E.
    Levy, Daniel
    Ramachandran, Vasan S.
    van der Harst, Pim
    van Gilst, Wiek H.
    Larson, Martin G.
    Shah, Sanjiv J.
    de Boer, Rudolf A.
    Lam, Carolyn S. P.
    Ho, Jennifer E.
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372